Recombinant Proteins
- (2)
- (2)
- (1)
- (2,981)
- (1)
- (23,536)
- (5)
- (1)
- (1)
- (68)
- (542)
- (9,493)
- (23)
- (1)
- (7)
- (2)
- (13)
- (5)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (256)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (157)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (1)
- (253)
- (3)
- (26,512)
- (1)
- (1)
- (2)
- (1)
- (32)
- (1)
- (37,971)
- (1,337)
- (2)
- (2)
- (8)
- (43)
- (3)
- (806)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (140)
- (4)
- (1)
- (110)
- (4,345)
- (3)
- (4)
- (6)
- (7)
- (5)
- (1)
- (1,469)
- (1)
- (1)
- (1)
- (14)
- (11,449)
- (50)
- (6)
- (8)
- (31)
- (21)
- (1)
- (45)
- (4)
- (110)
- (1)
- (34)
- (2)
- (3)
- (129)
- (4)
- (148)
- (98)
- (3)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,575)
- (2)
- (1)
- (160)
- (48)
- (2,559)
- (3)
- (1)
- (2)
- (9)
- (27)
- (1)
- (2)
- (21,948)
- (2,939)
- (4)
- (1)
- (2)
- (114)
- (2,860)
- (4)
- (4)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (34,932)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (6)
- (1)
- (1)
- (18,063)
- (6)
- (162)
- (4)
- (1)
- (14)
- (3)
- (1)
- (3)
- (2)
- (17)
- (19)
- (1)
- (3)
- (3)
- (4)
- (39,205)
- (1,835)
- (1)
- (3)
- (296)
- (9)
- (77,247)
- (1)
- (15)
- (1)
- (2)
- (52,354)
- (14,103)
- (245)
- (168)
- (77)
- (3,358)
- (2)
- (1)
- (2)
- (1)
- (90)
- (557)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (29)
- (2)
- (5)
- (9)
- (15)
- (1)
- (29)
- (72)
- (8)
- (27)
- (1)
- (1,377)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (6)
- (7)
- (1)
- (1)
- (38,027)
- (24)
- (22)
- (8)
- (5)
- (2,390)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (8)
- (45)
- (32)
- (24)
- (1)
- (2)
- (23)
- (445)
- (8)
- (9)
- (2)
- (5)
- (1)
- (2)
- (2)
- (2)
- (42)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,571)
- (1)
- (44)
- (1)
- (3)
- (79)
- (65,629)
Filtered Search Results
R&D Systems™ Recombinant Human alpha-L-Iduronidase/IDUA Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Enzyme Activity
R&D Systems™ Recombinant Human IL-2 Protein, Animal-Free
Contains the Cysteine to Serine substitution found in Proleukin™ (aldesleukin)
| Accession Number | P60568.1 |
|---|---|
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Conjugate | Unconjugated |
| Gene Alias | aldesleukin, IL2, IL-2, IL-2 lymphokine, interleukin 2, interleukin-2, involved in regulation of T-cell clonal expansion, Proleukin, T cell growth factor, T-cell growth factor, TCGF |
| Molecular Weight (g/mol) | M.W.-observed: 13 kDa, under reducing conditions., M.W.-theroretical: 15.5 kDa |
| Gene ID (Entrez) | 3558 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in Sodium Acetate with Trehalose. |
| Reconstitution | Reconstitute at 500 μg/mL in sterile deionized water. |
| Endotoxin Concentration | <0.01 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-2 |
| Source | E. coli-derived human IL-2 protein Ala21-Thr153 (Cys145Ser), with and without an N-terminal Met Produced using non-animal reagents in an animal-free laboratory. |
R&D Systems™ Recombinant Human VEGF 165 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 97%, by SDS-PAGE with silver staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | observed_molecular_weight: 20-22 kDa, under reducing conditions. 39-42 kDa, under non-reducing conditions. |
| Gene ID (Entrez) | 7422 |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Spodoptera frugiperda,Sf 21 (baculovirus)-derived human VEGF protein Ala27-Arg191 |
| Recombinant | Recombinant |
| Name | VEGF 165 |
| Form | Powder |
|---|---|
| Color | White |
| Synonym | Sodium Caseinate |
| Content And Storage | -20°C, Avoid Freeze/Thaw Cycles |
|---|---|
| Purity or Quality Grade | ≥95% as determined by SDS-PAGE. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IGHG1 |
| Molecular Weight (g/mol) | 26.08 kDa |
| Gene Symbol | IGHG1 |
| Activity | Immobilized Recombinant Human IgG1-Fc Protein (103 Cys/Ser) (Cat: 10702-HNAH) at 2μg/mL (100μL/well) can bind Recombinant Human CD64 / FCGR1A Protein (His Tag) (Cat: 10256-H08H), the EC50 is 1.6-4.8 ng/mL |
| Endotoxin Concentration | <1.0 EU/μg |
| Sequence | Human IgG1 Fc, amino acids Glu99-Lys330 (Accession # P01857-1) with a 103 Cys/Ser mutation |
| Concentration | 2.5 mg/mL |
| Expression System | HEK293 cells |
| For Use With (Application) | Binding Assay,Control,ELISA Standard |
| Name | Human IgG1 Fc (103 Cys/Ser) |
| Accession Number | P01857 |
| Purification Method | Purified |
| Gene Alias | IgG1; IgG3; Igh-4; Ighg; IGHG1; IGHG2; IGHG3; IGHG4; Immunoglobulin heavy chain (gamma polypeptide); immunoglobulin heavy constant gamma 1 (G1m marker); immunoglobulin heavy constant gamma 2 (G2m marker); immunoglobulin heavy constant gamma 3 (G3m marker); immunoglobulin heavy constant gamma 4 (G4m marker); RGD1359539; VH7183 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | 1. Measured by its ability to bind human CD16a-His in a functional ELISA. 2. Measured by its ability to bind human CD16a-AVI-His in a functional ELISA. 3.Measured by its ability to bind human CD16a-His in a functional ELISA. |
| Gene ID (Entrez) | 3500 |
| Formulation | PBS with 5% mannitol, 5% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human Cathepsin S Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Enzyme Activity
R&D Systems™ Recombinant Human Klotho (aa 34-981) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human Thrombopoietin Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 97%, by SDS-PAGE with silver staining. |
|---|---|
| Conjugate | Unconjugated |
| Gene Alias | Megakaryocyte colony-stimulating factor, Megakaryocyte growth and development factor, megakaryocyte stimulating factor, MGDF, MGDFC-mpl ligand, MKCSF, MK-CSF, ML, MPL ligand, MPLLG, MPLLGMGC163194, Myeloproliferative leukemia virus oncogene ligand, THCYT1, THPO, thrombopoietin, thrombopoietin nirs variant 1, Tpo, TPOMKCSF |
| Molecular Weight (g/mol) | 35 kDa |
| Gene ID (Entrez) | 7066 |
| Source | Spodoptera frugiperda,Sf 21 (baculovirus)-derived human Thrombopoietin/Tpo protein Ser22-Gly353 |
| Recombinant | Recombinant |
| Name | Thrombopoietin/Tpo |
R&D Systems™ Recombinant Human Myeloperoxidase Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Enzyme Activity
MP Biomedicals™ Immuno™ Albumin, Bovine, Low Endotoxin Powder (Heat-Shock)
Used to solubilize lipids, also used as blocking agent in Western blots or ELISA applications.
R&D Systems™ Recombinant Human Thrombopoietin R Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
MP Biomedicals™ Casein Hydrolysate, Vitamin-free, Salt-free Powder
A hydrochloric acid digest of casein in which the protein molecule has been substantially reduced to its constituent amino acids
| Water Content | <3% |
|---|---|
| Form | Powder |
| pH Range | 6.0 to 7.0 (2% solution) |
| Storage Requirements | Room temperature (15° to 30°C) |
| Name | Casein Hydrolysate, Vitamin and salt-free |
R&D Systems™ Recombinant Human IL-13 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Conjugate | Unconjugated |
|---|---|
| Molecular Weight (g/mol) | 12.3 kDa |
| Gene ID (Entrez) | 3596 |
R&D Systems™ Recombinant Human VEGF 165 Protein
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
| Accession Number | NP_001165097.1 |
|---|---|
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Conjugate | Unconjugated |
| Gene Alias | MVCD1, VAS, vascular endothelial growth factor A, Vascular permeability factor, Vasculotropin, VEGFA, VEGF-A, VEGFMGC70609, VPF, VPFvascular endothelial growth factor |
| Molecular Weight (g/mol) | M.W. Observed: 19-21 kDa, under reducing conditions., M.W. Theoretical: 19.2 kDa (monomer) |
| Gene ID (Entrez) | 7422 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in Sodium Acetate. |
| Reconstitution | Reconstitute the 10 μg size at 100 μg/mL in sterile deionized water. Reconstitute all other sizes at 500 μg/mL in sterile deionized water. |
| For Use With (Application) | Bioactivity |
| Protein | VEGF |